iCo Therapeutics Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.02 |
Market Cap |
$4.82 M |
Shares Outstanding |
84.46 M |
Public Float |
- |
iCo Therapeutics Inc. | |
Stock Exchange | Toronto Ventures Stock Exchange |
EPS |
CAD0.02 |
Market Cap |
CAD6.02 M |
Shares Outstanding |
109.46 M |
Public Float |
100.11 M |
Address |
777 Hornby Street Vancouver British Columbia V6Z 2T3 Canada |
Employees | - |
Website | http://www.icotherapeutics.com |
Updated | 07/08/2019 |
iCo Therapeutics, Inc. engages in the business of identification, development and commercialization of drug candidates for the treatment of sight- and life-threatening diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J. |